This suggests a model in which SOCS1 levels rise during SLE and inhibit the Stat1 responses to IL-6, IL-21, and interferons with comparatively little influence on Stat3 signaling including the Stat3 responses to IL-6 and IL-10. Here, SOCS1 is linked to systemic lupus erythematosus.